AI-generated summary
The authors report a double-blind randomized controlled trial of a red light device (655 nm) for female pattern hair loss, with 42 women completing the study. The active group showed a larger percent increase in hair counts than the sham group, and no adverse events were reported. The abstract notes the study involved a single scalp site and a single 16-week course of home treatment.
- Participants
- 42
- Who or what was studied
- Women aged 18 to 60 with androgenetic alopecia (Ludwig-Savin Baldness Scale patterns I-2 to II-2); 42 completed the study (24 active, 18 sham).
- Wavelengths
- 655 nm
- Limits stated in the abstract
- The abstract does not state a limitation explicitly; it reports a single scalp site and a single 16-week treatment course, and the reported percent increase is not clearly reconciled with the raw counts.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 655 nm
- Power
- 5 mW
- Total energy
- 2.9 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Sham, Light-emitting diode, Low-level laser therapy, Randomized controlled trial, Androgenetic alopecia, Irradiance, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.